Nephros Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Public

  • Employees
  • 36

Employees

  • Stock Symbol
  • NEPH

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $3.05
  • (As of Friday Closing)

Nephros General Information

Description

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

Contact Information

Website
www.nephros.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 380 Lackawanna Place
  • South Orange, NJ 07079
  • United States
+1 (201)
Primary Industry
Medical Supplies
Other Industries
Other Commercial Products
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 380 Lackawanna Place
  • South Orange, NJ 07079
  • United States
+1 (201)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nephros Stock Performance

As of 13-Nov-2026, Nephros’s stock price is $3.05. Its current market cap is $33.2M with 10.9M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.05 $3.31 $2.66 - $6.42 $33.2M 10.9M 44.8K $0.17

Nephros Financials Summary

As of 30-Sep-2026, Nephros has a trailing 12-month revenue of $21.6M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 36,466 47,841 14,535 32,436
Revenue 21,580 18,789 14,162 14,238
EBITDA 1,874 1,207 133 (1,423)
Net Income 1,911 1,194 74 (1,575)
Total Assets 15,305 13,641 11,210 11,861
Total Debt 774 1,063 1,411 1,836
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Nephros Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nephros‘s full profile, request access.

Request a free trial

Nephros Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and co
Medical Supplies
South Orange, NJ
36 As of 2025

Medolla, Italy
 

Osaka, Japan
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nephros Competitors (8)

One of Nephros’s 8 competitors is Grouppo Medica, a Corporation company based in Medolla, Italy.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Grouppo Medica Corporation Medolla, Italy
Nipro Corporation Osaka, Japan
Ruhof Private Equity-Backed Mineola, NY
Belimed Corporation Zug, Switzerland
Fresenius Medical Care Corporation Bad Homburg, Germany
You’re viewing 5 of 8 competitors. Get the full list »

Nephros Patents

Nephros Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210215577-A1 Portable system and process thereof to rapidly detect the presence, family of origin and ratio of any bacteria and estimate the endotoxin-producing bacteria levels of a water sample Inactive 15-Jan-2020
US-11964238-B2 Method and apparatus for forward and reverse flushable filter system Active 13-Nov-2019
US-20210138406-A1 Method and apparatus for forward and reverse flushable filter system Active 13-Nov-2019
US-20200340038-A1 Portable system and process thereof to rapidly filter, concentrate, and detect waterborne pathogens Inactive 25-Apr-2019
US-10821216-B1 Method and apparatus for a hemodiafiltration module for use with a dialysis machine Active 03-Jul-2017 A61M1/3413
To view Nephros’s complete patent history, request access »

Nephros Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nephros Acquisitions (2)

Nephros’s most recent deal was a Merger/Acquisition with GenArraytion for . The deal was made on 09-Jul-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
GenArraytion 09-Jul-2021 Merger/Acquisition Biotechnology
Biocon 1 31-Dec-2018 Merger/Acquisition Other Commercial Products
To view Nephros’s complete acquisitions history, request access »

Nephros ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

21 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Supplies

Subindustry

of 60

Rank

Percentile

To view Nephros’s complete esg history, request access »

Nephros Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Aether Water Systems Henderson, NV 2016

Nephros FAQs

  • When was Nephros founded?

    Nephros was founded in 1997.

  • Where is Nephros headquartered?

    Nephros is headquartered in South Orange, NJ.

  • What is the size of Nephros?

    Nephros has 36 total employees.

  • What industry is Nephros in?

    Nephros’s primary industry is Medical Supplies.

  • Is Nephros a private or public company?

    Nephros is a Public company.

  • What is Nephros’s stock symbol?

    The ticker symbol for Nephros is NEPH.

  • What is the current stock price of Nephros?

    As of 13-Nov-2026 the stock price of Nephros is $3.05.

  • What is the current market cap of Nephros?

    The current market capitalization of Nephros is $33.2M.

  • What is Nephros’s current revenue?

    The trailing twelve month revenue for Nephros is $21.6M.

  • Who are Nephros’s competitors?

    Grouppo Medica, Nipro, Ruhof, Belimed, and Fresenius Medical Care are some of the 8 competitors of Nephros.

  • What is Nephros’s annual earnings per share (EPS)?

    Nephros’s EPS for 12 months was $0.17.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process